Voisin Consulting Life Sciences publication icon
PublicationOrphan & Rare Disease

Accelerating development, registration and access to medicines for rare diseases in the European Union through adaptive approaches features and perspectives

Post thumbnail Accelerating development, registration and access to medicines for rare diseases in the European Union through adaptive approaches features and perspectives

Accelerating development, registration and access to medicines for rare diseases in the European Union through adaptive approaches: features and perspectives

There is growing recognition that the current research-and-development (R&D) and innovation-regulation ecosystem could be made more efficient to stimulate and support access to innovative therapies for those patients with rare, life-threatening diseases for which there are no adequate licensed therapies.

Emmanuelle Voisin, David Uguen

2014 – Orphanet Journal of Rare Diseases

Voisin Consulting Life Sciences download icon

Download the full publication now

Fill in the form to download the content

    Yes, I would like to receive communications regarding VCLS services and events

    publication by

    Emmanuelle M. Voisin, PhD
    Emmanuelle M. Voisin, PhD
    Founder and CEO
    Dr. Emmanuelle Voisin founded Voisin Consulting Life Sciences (VCLS) in 1997. The firm has become a leading advisor to Biotech,…
    View profile

    Voisin Consulting Life Sciences widget icon all our resources

    all our Resources

    More resources